VRTX
Vertex Pharmaceuticals Incorporated
$424.65
-$0.92(-0.22%)
62
Overall
45
Value
75
Tech
68
Quality
Market Cap
$108.30B
Volume
978.72K
52W Range
$362.50 - $519.88
Target Price
$490.60
EPS Estimates Overview
| Current Quarter | $4 | Next Quarter | $4.34 |
| Current Year | $15.89 | Next Year | $17.45 |
| QoQ Growth | +8.5% | YoY Growth | +9.8% |
| 3Y EPS CAGR | -30.6% | Target Price | $490.60 |
| Consensus | Buy | Upside | +15.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $424.65 | -0.2% | 978.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW